Ac-QS5-VS

A synthetic modified peptide.

Phase of research

Potential treatment - pre-clinical evidence

How it helps

Antiviral

Drug status

Experimental

Supporting references

Contradictory references

AI-suggested references

Clinical trials

Ac-QS5-VS is a synthetic modified peptide with inhibitory activity on the SARS-CoV-2 3C-like protease in vitro (Rut et al., 2020).

Ac-Abu-DTyr-Leu-Gln-VS

Link	Tested on	Impact factor	Notes	Publication date
SARS-CoV-2 Mpro inhibitors and activity-based probes for patient-sample imaging Small molecule Enzyme assay Peptide In vitro	in vitro enzyme assay; HeLa and HEK-293T cell lysates; Huh7 cells; SARS-CoV-2 strain BetaCov/Belgium/GHB-03021/2020 (EPI ISL 407976, 3 February 2020)	12.59	Inhibited the SARS-CoV-2 3C-like protease in vitro at non-cytotoxic levels.	Oct/22/2020